Evidence map›Paper›PMID 15684400›Full record

ArticleMolecular and cellular biology2005

Chromatin architecture near a potential 3' end of the igh locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites.

Francine E Garrett, Alexander V Emelyanov, Manuel A Sepulveda, Patrick Flanagan, Sabrina Volpi, Fubin Li, Dmitry Loukinov, Laurel A Eckhardt, Victor V Lobanenkov, Barbara K Birshtein

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 123 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Contribution of the IGCR1 regulatory element and the 3'Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Physiological role of the 3'IgH CBEs super-anchor in antibody class switching.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Francine E GarrettAlbert Einstein College of Medicine, Department of Cell Biology, Bronx, NY 10461, USA.
Alexander V Emelyanov
Manuel A Sepulveda
Patrick Flanagan
Sabrina Volpi
Fubin Li
Dmitry Loukinov
Laurel A Eckhardt
Victor V Lobanenkov
Barbara K Birshtein
Albert Einstein College of Medicine · USNational Institute of Allergy and Infectious Diseases · USCity University of New York · USHunter College · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
IMMUNOLOGY AND IMMUNUNOOCOLOGY TRAINING PROGRAMT32CA009173 · NCI · YESHIVA UNIVERSITY · PI NATHENSON, STANLEY G · 1985 to 2009
$5.8M
Gene Expression in Myeloma CellsR01AI030653 · NIAID · HUNTER COLLEGE · PI ECKHARDT, LAUREL A · 1990 to 2010
$3.4M
CELLULAR AND STRUCTURAL STUDIES OF MYELOMA MUTANTSR01AI013509 · NIAID · YESHIVA UNIVERSITY · PI BIRSHTEIN, BARBARA · 1985 to 2009
$2.9M
Transcriptional Regulation Of Ctcf And Boris ExpressionZ01AI000860 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI LOBANENKOV, VICTOR · 2000 to 2008
$1.5M
PREDOCTORAL FELLOWSHIP FOR MINORITY STUDENTSF31CA076942 · NCI · YESHIVA UNIVERSITY · PI GARRETT, FRANCINE E · 1997 to 2000
$38k
CELLULAR AND STRUCTURAL STUDIES OF MYELOMA MUTANTSR37AI013509 · NIAID · YESHIVA UNIVERSITY · PI BIRSHTEIN, BARBARA · 1989 to 1998
–
NCI NIH HHS 5 F31 CA76942NCI NIH HHS F31 CA076942NCI NIH HHS P30 CA013330NCI NIH HHS P30CA13330NCI NIH HHS T32 CA009173NCI NIH HHS T32 CA09173NIAID NIH HHS AI13509NIAID NIH HHS AI30653NIAID NIH HHS R01 AI013509NIAID NIH HHS R01 AI030653NIAID NIH HHS R37 AI013509
6 · The paper itself

Abstract

The murine Igh locus has a 3' regulatory region (3' RR) containing four enhancers (hs3A, hs1,2, hs3B, and hs4) at DNase I-hypersensitive sites. The 3' RR exerts long-range effects on class switch recombination (CSR) to several isotypes through its control of germ line transcription. By measuring levels of acetylated histones H3 and H4 and of dimethylated H3 (K4) with chromatin immunoprecipitation assays, we found that early in B-cell development, chromatin encompassing the enhancers of the 3' RR began to attain stepwise modifications typical of an open conformation. The hs4 enhancer was associated with active chromatin initially in pro- and pre-B cells and then together with hs3A, hs1,2, and hs3B in B and plasma cells. Histone modifications were similar in resting splenic B cells and in splenic B cells induced by lipopolysaccharide to undergo CSR. From the pro-B-cell stage onward, the approximately 11-kb region immediately downstream of hs4 displayed H3 and H4 modifications indicative of open chromatin. This region contained newly identified DNase I-hypersensitive sites and several CTCF target sites, some of which were occupied in vivo in a developmentally regulated manner. The open chromatin environment of the extended 3' RR in mature B cells was flanked by regions associated with dimethylated K9 of histone H3. Together, these data suggest that 3' RR elements are located within a specific chromatin subdomain that contains CTCF binding sites and developmentally regulated modules.

Indexed as

3' Flanking RegionAcetylationAnimalsB-LymphocytesBone MarrowCCCTC-Binding FactorChromatinDeoxyribonuclease IDNA-Binding ProteinsDNA PrimersEnhancer Elements, GeneticHistonesImmunoglobulin Class SwitchingLipopolysaccharidesLocus Control RegionMiceCCCTC-Binding FactorChromatinCtcf protein, mouseDeoxyribonuclease IDNA-Binding ProteinsDNA PrimersHistonesLipopolysaccharidesRepressor Proteins

Identifiers

PMID15684400
PMCPMC548023
OpenAlexW2098452980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.